PEDEGO Research Unit, University of Oulu, Oulu, Finland.
Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
Dev Med Child Neurol. 2021 Sep;63(9):1066-1074. doi: 10.1111/dmcn.14884. Epub 2021 May 5.
To examine the epidemiological, clinical, and genetic characteristics of paediatric patients with genetic white matter disorders (GWMDs) in Northern Finland.
A longitudinal population-based cohort study was conducted in the tertiary catchment area of Oulu University Hospital from 1990 to 2019. Patients were identified retrospectively by International Statistical Classification of Diseases and Related Health Problems codes in hospital records and prospectively by attending physicians. Inclusion criteria were children younger than 18 years with defined GWMDs or genetic disorders associated with white matter abnormalities (WMAs) on brain magnetic resonance imaging.
Eighty patients (mean age [SD] at the end of the study 11y [8y 6mo], range 0-35y; 45 males, 35 females) were diagnosed with a defined GWMD. The cumulative childhood incidence was 30 per 100 000 live births. Regarding those patients with 49 distinct GWMDs, 20% had classic leukodystrophies and 80% had genetic leukoencephalopathies. The most common leukodystrophies were cerebral adrenoleukodystrophy, Krabbe disease, and Salla disease. Additionally, 29 patients (36%) had genetic aetiologies not previously associated with brain WMAs or they had recently characterised GWMDs, including SAMD9L- and NHLRC2-related neurological disorders. Aetiology was mitochondrial in 21% of patients. The most common clinical findings were motor developmental delay, intellectual disability, hypotonia, and spasticity.
The cumulative childhood incidence of childhood-onset GWMDs was higher than previously described. Comprehensive epidemiological and natural history data are needed before future clinical trials are undertaken. What this paper adds Forty-nine distinct genetic white matter disorders (GWMDs) were identified, with 20% of cases being classic leukodystrophies. The cumulative childhood incidence of GWMDs was higher than described previously. A considerable proportion (36%) of GWMDs were previously undefined or recently characterised GWMDs. Mitochondrial aetiology was more common (21%) than previously reported.
研究芬兰北部儿科遗传性脑白质疾病(GWMD)患者的流行病学、临床和遗传学特征。
在奥卢大学医院的三级治疗区进行了一项 1990 年至 2019 年的纵向基于人群的队列研究。通过医院记录中的国际疾病分类和相关健康问题代码进行回顾性患者识别,通过主治医生进行前瞻性患者识别。纳入标准为年龄在 18 岁以下、有明确 GWMD 或脑磁共振成像显示有脑白质异常(WMAs)的遗传疾病的儿童。
共诊断出 80 例(研究结束时的平均年龄[标准差]为 11 岁[8 岁 6 个月],范围 0-35 岁;男性 45 例,女性 35 例)明确 GWMD 患者。儿童累积发病率为每 100000 例活产儿 30 例。在 49 种不同的 GWMD 患者中,20%为经典白质营养不良症,80%为遗传性脑白质病。最常见的白质营养不良症是脑肾上腺脑白质营养不良症、Krabbe 病和 Salla 病。此外,29 例(36%)患者的病因与脑 WMAs 无关,或者是最近确定的 GWMD,包括 SAMD9L 和 NHLRC2 相关的神经病变。21%的患者病因是线粒体。最常见的临床发现是运动发育迟缓、智力障碍、肌张力低下和痉挛。
儿童 GWMD 的儿童期累积发病率高于以前的描述。在进行未来的临床试验之前,需要有全面的流行病学和自然病史数据。本文的意义:确定了 49 种不同的遗传性脑白质疾病(GWMD),其中 20%为经典白质营养不良症。GWMD 的儿童期累积发病率高于以前的描述。相当一部分(36%)的 GWMD 以前未定义或最近确定的 GWMD。线粒体病因比以前报道的更常见(21%)。